CA1341252C - Interferon-.beta.2a humain et interferon-.beta.2b humain; vecteurs contenant des genes correspondant a ces interferons: lignees cellulaires produisant ces interferons, ainsi que l'utilisation de ces interferons comme produits pharmaceutiques - Google Patents

Interferon-.beta.2a humain et interferon-.beta.2b humain; vecteurs contenant des genes correspondant a ces interferons: lignees cellulaires produisant ces interferons, ainsi que l'utilisation de ces interferons comme produits pharmaceutiques

Info

Publication number: CA1341252C
Authority: CA; Canada
Prior art keywords: leu; glu; ser; gln; lys
Prior art date: 1986-10-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA000617130A

Other languages

English (en)

Inventor

Michel Revel

Asher Zilberstein

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Yeda Research and Development Co Ltd

Original Assignee

Yeda Research and Development Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-10-10

Filing date

1986-10-10

Publication date

2001-06-12

1986-10-10 Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd

1986-10-10 Priority claimed from CA000520275A external-priority patent/CA1341369C/fr

2001-06-12 Application granted granted Critical

2001-06-12 Publication of CA1341252C publication Critical patent/CA1341252C/fr

2018-06-12 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

108090000623 proteins and genes Proteins 0.000 title claims abstract description 71
239000013598 vector Substances 0.000 title claims description 50
108010050904 Interferons Proteins 0.000 title abstract description 29
102000014150 Interferons Human genes 0.000 title abstract description 28
229940047124 interferons Drugs 0.000 title abstract description 7
239000003814 drug Substances 0.000 title description 3
239000002299 complementary DNA Substances 0.000 claims abstract description 55
238000000034 method Methods 0.000 claims abstract description 42
210000004962 mammalian cell Anatomy 0.000 claims abstract 13
210000004027 cell Anatomy 0.000 claims description 130
108020004414 DNA Proteins 0.000 claims description 41
230000008569 process Effects 0.000 claims description 41
125000003275 alpha amino acid group Chemical group 0.000 claims description 25
230000014509 gene expression Effects 0.000 claims description 15
239000002773 nucleotide Substances 0.000 claims description 15
125000003729 nucleotide group Chemical group 0.000 claims description 15
229920001184 polypeptide Polymers 0.000 claims description 15
102000004196 processed proteins & peptides Human genes 0.000 claims description 15
108090000765 processed proteins & peptides Proteins 0.000 claims description 15
210000004978 chinese hamster ovary cell Anatomy 0.000 claims description 11
241000699800 Cricetinae Species 0.000 claims description 9
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims description 9
229960000485 methotrexate Drugs 0.000 claims description 9
239000012634 fragment Substances 0.000 claims description 8
239000013612 plasmid Substances 0.000 claims description 8
230000001105 regulatory effect Effects 0.000 claims description 8
108091034117 Oligonucleotide Proteins 0.000 claims description 2
230000003321 amplification Effects 0.000 claims description 2
238000003199 nucleic acid amplification method Methods 0.000 claims description 2
108091028043 Nucleic acid sequence Proteins 0.000 claims 16
210000003527 eukaryotic cell Anatomy 0.000 claims 8
230000001580 bacterial effect Effects 0.000 claims 6
239000013604 expression vector Substances 0.000 claims 6
238000012258 culturing Methods 0.000 claims 4
230000001131 transforming effect Effects 0.000 claims 4
241000699802 Cricetulus griseus Species 0.000 claims 2
239000003937 drug carrier Substances 0.000 claims 2
210000001672 ovary Anatomy 0.000 claims 2
239000008194 pharmaceutical composition Substances 0.000 claims 2
210000001236 prokaryotic cell Anatomy 0.000 claims 2
230000009466 transformation Effects 0.000 claims 1
230000000840 anti-viral effect Effects 0.000 abstract description 16
210000005260 human cell Anatomy 0.000 abstract description 11
238000004519 manufacturing process Methods 0.000 abstract description 5
102000004127 Cytokines Human genes 0.000 abstract description 4
108090000695 Cytokines Proteins 0.000 abstract description 4
230000028327 secretion Effects 0.000 abstract description 4
108020004511 Recombinant DNA Proteins 0.000 abstract description 3
230000004071 biological effect Effects 0.000 abstract description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 38
101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 description 38
102100040019 Interferon alpha-1/13 Human genes 0.000 description 36
YPHMISFOHDHNIV-FSZOTQKASA-N cycloheximide Chemical compound C1[C@@H](C)C[C@H](C)C(=O)[C@@H]1[C@H](O)CC1CC(=O)NC(=O)C1 YPHMISFOHDHNIV-FSZOTQKASA-N 0.000 description 32
102000004169 proteins and genes Human genes 0.000 description 25
101100508407 Caenorhabditis elegans mua-6 gene Proteins 0.000 description 24
210000002950 fibroblast Anatomy 0.000 description 23
230000000694 effects Effects 0.000 description 22
229940079322 interferon Drugs 0.000 description 21
230000006698 induction Effects 0.000 description 18
108020004999 messenger RNA Proteins 0.000 description 18
102000000589 Interleukin-1 Human genes 0.000 description 11
108010002352 Interleukin-1 Proteins 0.000 description 11
108060008682 Tumor Necrosis Factor Proteins 0.000 description 11
102000003390 tumor necrosis factor Human genes 0.000 description 11
230000012010 growth Effects 0.000 description 7
239000002609 medium Substances 0.000 description 7
230000037452 priming Effects 0.000 description 7
241000894007 species Species 0.000 description 7
241000711975 Vesicular stomatitis virus Species 0.000 description 6
150000001413 amino acids Chemical class 0.000 description 6
230000004044 response Effects 0.000 description 6
102000003960 Ligases Human genes 0.000 description 5
108090000364 Ligases Proteins 0.000 description 5
230000003305 autocrine Effects 0.000 description 5
210000000349 chromosome Anatomy 0.000 description 5
239000000047 product Substances 0.000 description 5
102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
108020004635 Complementary DNA Proteins 0.000 description 4
239000003298 DNA probe Substances 0.000 description 4
108700026244 Open Reading Frames Proteins 0.000 description 4
238000003556 assay Methods 0.000 description 4
101150070234 31 gene Proteins 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
230000010261 cell growth Effects 0.000 description 3
230000000120 cytopathologic effect Effects 0.000 description 3
239000003102 growth factor Substances 0.000 description 3
238000003018 immunoassay Methods 0.000 description 3
239000000411 inducer Substances 0.000 description 3
239000006166 lysate Substances 0.000 description 3
244000005700 microbiome Species 0.000 description 3
238000006386 neutralization reaction Methods 0.000 description 3
210000000287 oocyte Anatomy 0.000 description 3
238000012163 sequencing technique Methods 0.000 description 3
239000001957 sucroglyceride Substances 0.000 description 3
238000001890 transfection Methods 0.000 description 3
238000013519 translation Methods 0.000 description 3
102100024746 Dihydrofolate reductase Human genes 0.000 description 2
108700024394 Exon Proteins 0.000 description 2
108700039691 Genetic Promoter Regions Proteins 0.000 description 2
102000003886 Glycoproteins Human genes 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
102000003996 Interferon-beta Human genes 0.000 description 2
108090000467 Interferon-beta Proteins 0.000 description 2
102000004889 Interleukin-6 Human genes 0.000 description 2
108090001005 Interleukin-6 Proteins 0.000 description 2
101710163270 Nuclease Proteins 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000011712 cell development Effects 0.000 description 2
230000001461 cytolytic effect Effects 0.000 description 2
230000004069 differentiation Effects 0.000 description 2
108020001096 dihydrofolate reductase Proteins 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
238000002169 hydrotherapy Methods 0.000 description 2
230000008488 polyadenylation Effects 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
238000012545 processing Methods 0.000 description 2
230000035755 proliferation Effects 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
239000000523 sample Substances 0.000 description 2
239000013049 sediment Substances 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
230000010474 transient expression Effects 0.000 description 2
230000014616 translation Effects 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
101150084750 1 gene Proteins 0.000 description 1
RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
206010048998 Acute phase reaction Diseases 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
101150076489 B gene Proteins 0.000 description 1
101100508406 Caenorhabditis elegans ifa-1 gene Proteins 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
102000029816 Collagenase Human genes 0.000 description 1
108060005980 Collagenase Proteins 0.000 description 1
241000557626 Corvus corax Species 0.000 description 1
101000972324 Cynodon dactylon Leaf protein Proteins 0.000 description 1
101150074155 DHFR gene Proteins 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
101150103227 IFN gene Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
108010047761 Interferon-alpha Proteins 0.000 description 1
102000006992 Interferon-alpha Human genes 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
108091036407 Polyadenylation Proteins 0.000 description 1
229940123573 Protein synthesis inhibitor Drugs 0.000 description 1
241000219061 Rheum Species 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
208000034189 Sclerosis Diseases 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
108700026226 TATA Box Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
241000700605 Viruses Species 0.000 description 1
108091027569 Z-DNA Proteins 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000004658 acute-phase response Effects 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
101150010487 are gene Proteins 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
230000008512 biological response Effects 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
210000004671 cell-free system Anatomy 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000010367 cloning Methods 0.000 description 1
229960002424 collagenase Drugs 0.000 description 1
108091092330 cytoplasmic RNA Proteins 0.000 description 1
229960000640 dactinomycin Drugs 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
230000029087 digestion Effects 0.000 description 1
239000012895 dilution Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
239000000284 extract Substances 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
230000004927 fusion Effects 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
210000003917 human chromosome Anatomy 0.000 description 1
229920002674 hyaluronan Polymers 0.000 description 1
229960003160 hyaluronic acid Drugs 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
239000012133 immunoprecipitate Substances 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
239000003999 initiator Substances 0.000 description 1
229960003130 interferon gamma Drugs 0.000 description 1
229960001388 interferon-beta Drugs 0.000 description 1
238000011835 investigation Methods 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
238000013507 mapping Methods 0.000 description 1
230000035800 maturation Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
229960000907 methylthioninium chloride Drugs 0.000 description 1
239000003226 mitogen Substances 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
230000035409 positive regulation of cell proliferation Effects 0.000 description 1
YXUKIOYEWGMHBJ-UHFFFAOYSA-M potassium;2-aminoethanesulfonate;dodecanoic acid Chemical compound [K+].NCCS([O-])(=O)=O.CCCCCCCCCCCC(O)=O YXUKIOYEWGMHBJ-UHFFFAOYSA-M 0.000 description 1
239000000007 protein synthesis inhibitor Substances 0.000 description 1
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
210000001995 reticulocyte Anatomy 0.000 description 1
238000011451 sequencing strategy Methods 0.000 description 1
239000000243 solution Substances 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/565—IFN-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

CA000617130A 1986-10-10 1986-10-10 Interferon-.beta.2a humain et interferon-.beta.2b humain; vecteurs contenant des genes correspondant a ces interferons: lignees cellulaires produisant ces interferons, ainsi que l'utilisation de ces interferons comme produits pharmaceutiques Expired - Lifetime CA1341252C (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000520275A CA1341369C (fr)	1985-10-14	1986-10-10	Interferons .beta.2a et .beta.2b humains; vecteurs contenant des genes codant pour lesdits interferons, lignees de cellules les produisant et utilisation desdits interferons a titre de medicament

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000520275A Division CA1341369C (fr)	1985-10-14	1986-10-10	Interferons .beta.2a et .beta.2b humains; vecteurs contenant des genes codant pour lesdits interferons, lignees de cellules les produisant et utilisation desdits interferons a titre de medicament

Publications (1)

Publication Number	Publication Date
CA1341252C true CA1341252C (fr)	2001-06-12

Family

ID=4134134

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000617130A Expired - Lifetime CA1341252C (fr)	1986-10-10	1986-10-10	Interferon-.beta.2a humain et interferon-.beta.2b humain; vecteurs contenant des genes correspondant a ces interferons: lignees cellulaires produisant ces interferons, ainsi que l'utilisation de ces interferons comme produits pharmaceutiques

Country Status (1)

Country	Link
CA (1)	CA1341252C (fr)

1986
- 1986-10-10 CA CA000617130A patent/CA1341252C/fr not_active Expired - Lifetime

Legal Events

Date	Code	Title	Description
2018-08-14	MKEX	Expiry	Effective date: 20180612

Publication	Publication Date	Title
US5554513A (en)	1996-09-10	Production of recombinant human interferon-beta2
Taniguchi et al.	1980	The nucleotide sequence of human fibroblast interferon cDNA
US4889803A (en)	1989-12-26	Production of interferon gamma
EP0220574B2 (fr)	2000-04-12	Interféron bêta2A humain; vecteurs contenant des gènes codant pour ledit interféron, lignées de cellules le produisant et utilisation dudit interféron à titre de médicament
Zilberstein et al.	1986	Structure and expression of cDNA and genes for human interferon‐beta‐2, a distinct species inducible by growth‐stimulatory cytokines.
Capon et al.	1985	Two distinct families of human and bovine interferon-α genes are coordinately expressed and encode functional polypeptides
Charleston et al.	1993	An interferon-induced Mx protein: cDNA sequence and high-level expression in the endometrium of pregnant sheep
JP2515308B2 (ja)	1996-07-10	ヒト免疫インタ−フエロン
Yelverton et al.	1981	Bacterial synthesis of a novel human leukocyte interferon
Poupart et al.	1987	B cell growth modulating and differentiating activity of recombinant human 26‐kd protein (BSF‐2, HuIFN‐beta 2, HPGF).
Derynck et al.	1980	Isolation and structure of a human fibroblast interferon gene
Ohno et al.	1981	Structure of a chromosomal gene for human interferon β
US5004689A (en)	1991-04-02	DNA sequences, recombinant DNA molecules and processes for producing human gamma interferon-like polypeptides in high yields
Chernajovsky et al.	1984	Efficient constitutive production of human fibroblast interferon by hamster cells transformed with the IFN-β1 gene fused to an SV40 early promoter
Leung et al.	1984	The structure and bacterial expression of three distinct bovine interferon-β genes
EP0750668A1 (fr)	1997-01-02	NOUVELLES MUTEINES D'INTERFERON $g(b)
Mory et al.	1986	Efficient constitutive production of human IFN-γ in Chinese hamster ovary cells
JP2648860B2 (ja)	1997-09-03	ヒトインターフエロン−β２Ａ及びヒトインターフエロン−β２Ｂ、該インターフエロンをコードする遺伝子を含むベクター、該インターフエロンを産生するセルライン及び該インターフエロンの医薬品としての用途
Coulombel et al.	1991	Isolation and characterization of a novel interferon-α-encoding gene, IFN-α11 within a murine IFN cluster
US4939088A (en)	1990-07-03	Sustained production of recombinant gamma interferon using an Epstein-Barr virus replicon
US5510472A (en)	1996-04-23	Production of recombinant human interferon-beta2
Haas et al.	1992	Constitutive monocyte-restricted activity of NF-M, a nuclear factor that binds to a C/EBP motif
CA1341252C (fr)	2001-06-12	Interferon-.beta.2a humain et interferon-.beta.2b humain; vecteurs contenant des genes correspondant a ces interferons: lignees cellulaires produisant ces interferons, ainsi que l'utilisation de ces interferons comme produits pharmaceutiques
EP0174143A1 (fr)	1986-03-12	Famille distincte d'interférons de leucocytes humains, compositions les contenant, méthodes pour leur production et ADN et hôtes transfectés pour ces méthodes
KR100382628B1 (ko)	2004-02-25	인터페론α/β결합단백질과이의제조및용도